Likopid tablets 10mg in bl pack. №10х1

Name:
Likopid tab 10mg in bl pack. No. 10х1
Description:
Tablets of white color, round, ploskotsilindrichesky, with a facet and risk. The main active ingredient Glucosaminylmuramyl dipeptide Release form Tablets are white, round, flat-cylindrical, with a chamfer and a risk mark. 1 tab. GMDP (glucosaminylmuramyl dipeptide) 10 mg Excipients: lactose, sucrose, potato starch, methylcellulose, calcium stearate. 10 pieces. – cellular contour packings (1) – packs of cardboard. 10 pieces. – cellular contour packings (2) – packs of cardboard. Dosage For adults, for the prevention of postoperative complications, Licopid® is prescribed sublingually at 1 mg 1 time / day for 10 days. For the treatment of purulent-septic processes of the skin and soft tissues of moderate severity (including postoperative ones), Likopid® is prescribed sublingually at 2 mg 2-3 times / day for 10 days. For the treatment of severe forms of purulent-septic processes of the skin and soft tissues, Licopid® is administered orally at 10 mg 1 time / day for 10 days. In chronic infections of the upper and lower respiratory tract, Likopid® is prescribed sublingually, 1-2 mg 1 time / day for 10 days. In pulmonary tuberculosis, Likopid® is administered orally at 10 mg 1 time / day for 10 days. With a mild form of herpetic infection, Likopid® is prescribed sublingually, 2 mg 1-2 times / day for 6 days; in severe form – sublingually 10 mg 1-2 times / day for 6 days. With ophthalmic herpes, Likopid® is used orally at 10 mg 2 times / day for 3 days. After a break of 3 days, the course of treatment is repeated. When the cervix is affected by the human papillomavirus, Likopid® is administered orally at 10 mg 1 time / day for 10 days. For the treatment of psoriasis, Likopid® is administered orally at a dose of 10-20 mg 1-2 times / day for 10 days and then every other day, 10-20 mg for the next 10 days, in severe forms and a large area of damage (including . with arthropathic form) – inside 10 mg 2 times / day for 20 days. For children aged 1 to 16 years, Likopid® is prescribed in the form of 1 mg tablets. In the treatment of chronic respiratory tract infections and pyoinflammatory skin diseases, Likopid® is administered orally at a dose of 1 mg 1 time / day for 10 days. In the treatment of herpes infection, the drug is administered orally at a dose of 1 mg 3 times / day for 10 days. In the treatment of chronic viral hepatitis B and C – orally at a dose of 1 mg 3 times / day for 20 days. For newborns with a protracted course of infectious diseases (including pneumonia, bronchitis, enterocolitis, sepsis, postoperative complications), Likopid® is administered orally at a dose of 500 mcg 2 times / day for 7-10 days. Special instructions It is not advisable to co-administer Likopid with sulfanilamide preparations and tetracyclines. Influence on the ability to drive vehicles and control mechanisms The use of the drug Likopid® does not affect the ability to perform work that requires increased attention and speed of psychomotor reactions. Pharmacological action Immunostimulating drug, the biological activity of which is due to the presence of specific binding sites (receptors) to GMDP, localized in the endoplasm of phagocytes and T-lymphocytes. The drug stimulates the functional (bactericidal, cytotoxic) activity of phagocytes (neutrophils, macrophages), enhances the proliferation of T- and B-lymphocytes, increases the synthesis of specific antibodies. Pharmacological action is carried out by enhancing the production of interleukins (interleukin-1, interleukin-6, interleukin-12), tumor necrosis factor-alpha, gamma-interferon, colony-stimulating factors. The drug increases the activity of natural killer cells. Pharmacokinetics Absorption and distribution of Cmax of the active substance in plasma is achieved 1.5 hours after ingestion. Bioavailability when taken orally is 7-13%. The degree of binding to blood albumin is weak. Metabolism and excretion No active metabolites are formed. T1 / 2 is 4.29 hours. It is excreted unchanged, mainly in the urine. Indications for use As part of complex therapy for conditions accompanied by secondary immunodeficiencies, including: Tablets 1 mg and 10 mg (for adults) for chronic lung infections; for acute and chronic purulent-inflammatory diseases of the skin and soft tissues (including purulent-septic postoperative complications); with herpes infection (including with ophthalmic herpes); with papillomavirus infection; with chronic viral hepatitis B and C; with psoriasis (including with arthropathic form); with pulmonary tuberculosis. Tablets 1 mg (for children) for acute and chronic purulent-inflammatory diseases of the skin and soft tissues; for chronic infections of the upper and lower respiratory tract, both in the acute stage and in remission; for herpetic infections of any localization; for chronic viral hepatitis B and C. Dosage and administration Likopid® administered sublingually or inside on an empty stomach, 30 minutes before meals. For adults, for the prevention of postoperative complications, Likopid® is prescribed sublingually at a dose of 1 mg 1 time / day for 10 days. For the treatment of purulent-septic processes of the skin and soft tissues of moderate severity (including postoperative ones), Likopid® is prescribed sublingually at 2 mg 2-3 times / day for 10 days. For the treatment of severe forms of purulent-septic processes of the skin and soft tissues, Licopid® is administered orally at 10 mg 1 time / day for 10 days. In chronic infections of the upper and lower respiratory tract, Likopid® is prescribed sublingually, 1-2 mg 1 time / day for 10 days. In pulmonary tuberculosis, Likopid® is administered orally at 10 mg 1 time / day for 10 days. With a mild form of herpetic infection, Likopid® is prescribed sublingually, 2 mg 1-2 times / day for 6 days; in severe form – sublingually 10 mg 1-2 times / day for 6 days. With ophthalmic herpes, Likopid® is used orally at 10 mg 2 times / day for 3 days. After a break of 3 days, the course of treatment is repeated. When the cervix is affected by the human papillomavirus, Likopid® is administered orally at 10 mg 1 time / day for 10 days. For the treatment of psoriasis, Likopid® is administered orally at a dose of 10-20 mg 1-2 times / day for 10 days and then every other day, 10-20 mg for the next 10 days, in severe forms and a large area of damage (including . with arthropathic form) – inside 10 mg 2 times / day for 20 days. For children aged 1 to 16 years, Likopid® is prescribed in the form of 1 mg tablets. In the treatment of chronic respiratory tract infections and pyoinflammatory skin diseases, Likopid® is administered orally at a dose of 1 mg 1 time / day for 10 days. In the treatment of herpes infection, the drug is administered orally at a dose of 1 mg 3 times / day for 10 days. In the treatment of chronic viral hepatitis B and C – orally at a dose of 1 mg 3 times / day for 20 days. For newborns with a protracted course of infectious diseases (including pneumonia, bronchitis, enterocolitis, sepsis, postoperative complications), Likopid® is administered orally at a dose of 500 mcg 2 times / day for 7-10 days. Use during pregnancy and lactation The use of the drug during pregnancy and lactation (breastfeeding) is contraindicated. Precautions For children aged 1 to 16 years, Licopid® is prescribed in the form of 1 mg tablets. Interaction with other drugs With the simultaneous use of Licopid® increases the effect of antibiotics from the group of semi-synthetic penicillins, cephalosporins, polyene derivatives, fluoroquinolones, there is synergism in relation to antiviral and antifungal drugs. Antacids and adsorbents, when used simultaneously with Likopid, significantly reduce its bioavailability. GCS with simultaneous use reduce the effectiveness of Likopid. Contraindications autoimmune thyroiditis in the acute phase; diseases accompanied by high fever or hyperthermia (> 38 ° C); pregnancy; lactation period (breastfeeding); hypersensitivity to the drug. Composition GMDP (glucosaminylmuramyl dipeptide) 10 mg Excipients: lactose, sucrose, starch potatoes, methylcellulose, calcium stearate. Overdose Likopid® administered sublingually or inside on an empty stomach, 30 minutes before meals. For adults, for the prevention of postoperative complications, Likopid® is prescribed sublingually at a dose of 1 mg 1 time / day for 10 days. For the treatment of purulent-septic processes of the skin and soft tissues of moderate severity (including postoperative ones), Likopid® is prescribed sublingually at 2 mg 2-3 times / day for 10 days. For the treatment of severe forms of purulent-septic processes of the skin and soft tissues, Licopid® is administered orally at 10 mg 1 time / day for 10 days. In chronic infections of the upper and lower respiratory tract, Likopid® is prescribed sublingually, 1-2 mg 1 time / day for 10 days. In pulmonary tuberculosis, Likopid® is administered orally at 10 mg 1 time / day for 10 days. With a mild form of herpetic infection, Likopid® is prescribed sublingually, 2 mg 1-2 times / day for 6 days; in severe form – sublingually 10 mg 1-2 times / day for 6 days. With ophthalmic herpes, Likopid® is used orally at 10 mg 2 times / day for 3 days. After a break of 3 days, the course of treatment is repeated. When the cervix is affected by the human papillomavirus, Likopid® is administered orally at 10 mg 1 time / day for 10 days. For the treatment of psoriasis, Likopid® is administered orally at a dose of 10-20 mg 1-2 times / day for 10 days and then every other day, 10-20 mg for the next 10 days, in severe forms and a large area of damage (including . with arthropathic form) – inside 10 mg 2 times / day for 20 days. For children aged 1 to 16 years, Likopid® is prescribed in the form of 1 mg tablets. In the treatment of chronic respiratory tract infections and pyoinflammatory skin diseases, Likopid® is administered orally at a dose of 1 mg 1 time / day for 10 days. In the treatment of herpes infection, the drug is administered orally at a dose of 1 mg 3 times / day for 10 days. In the treatment of chronic viral hepatitis B and C – orally at a dose of 1 mg 3 times / day for 20 days. For newborns with a protracted course of infectious diseases (including pneumonia, bronchitis, enterocolitis, sepsis, postoperative complications), Likopid® is administered orally at a dose of 500 mcg 2 times / day for 7-10 days. Side effects Possible: at the beginning of treatment – an increase in body temperature to 37.9 ° C (it is short-term, passes on its own and does not require discontinuation of the drug). Storage conditions The drug should be stored in a dry, dark place out of the reach of children at a temperature not higher than 25 ° C Buy Likopid tablets 10mg in bl pack. No. 10×1 Price for Licopid tablets 10 mg in bl pack. No. 10×1 Instructions for use for Licopid tablets 10 mg in bl pack. №10х1